• 儀器無(wú)憂網(wǎng)首頁(yè)
首頁(yè) >  儀器無(wú)憂網(wǎng)品牌優(yōu)搜庫(kù) >  O > OraSure

加拿大 . OraSure

logo

OraSure

加拿大OraSure Technologies www.orasure.com
OraSure 技術(shù)有限公司使用其特有的唾液檢測(cè)技術(shù),開發(fā)、制造、銷售了唾液采樣儀。其診斷產(chǎn)品包括免疫分析以及其他體外診斷儀、醫(yī)療儀器等。這些產(chǎn)品在美國(guó)以及全世界的臨床實(shí)驗(yàn)室、經(jīng)銷商、政府機(jī)構(gòu)以及醫(yī)療、商業(yè)和工業(yè)機(jī)構(gòu)進(jìn)行銷售。
除此以外,OraSure還在美國(guó)、加拿大、部分歐洲國(guó)家、澳大利亞、新西蘭的非處方與零售市場(chǎng),銷售冷凍去除尋常疣、足底疣的產(chǎn)品,并在美國(guó)和眾多國(guó)家的專業(yè)或者醫(yī)療市場(chǎng)提供冷凍去除尋常疣、足底疣以及其他良性皮膚損傷的產(chǎn)品。

Based in Bethlehem, Pennsylvania, OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions.
These products include tests for the detection of antibodies to the HIV virus, including OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test and the OraSure® HIV-1 Oral Specimen Collection Device, a test for antibodies to the HCV virus, the OraQuick® HCV Rapid Antibody Test, and oral fluid testing solutions for drugs of abuse testing, including Intercept® Oral Fluid Drug Testing System and Q.E.D.® Saliva Alcohol Test.
OraSure also manufactures and sells several leading cryosurgical products. These include: Histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product for the cryosurgical removal of common and plantar warts.
In addition, through its wholly-owned subsidiary, DNA Genotek Inc., the Company also is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.
OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities.